Lipophilicity in drug discovery
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
IMPORTANCE OF THE FIELD: The role of lipophilicity in determining the overall quality of candidate drug molecules is of paramount importance. Recent developments suggest that, as well as determining pre-clinical ADMET (absorption, distribution, metabolism, elimination and toxicology) properties, compounds of optimal lipophilicity might have increased chances of success in development. AREAS COVERED IN THIS REVIEW: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compound 'quality' with lipophilicity. WHAT THE READER WILL GAIN: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region. TAKE HOME MESSAGE: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3. Some of the implications of this for medicinal chemistry optimisation are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420 · cited 1×
“have proposed guidelines based on rat bioavailability that focus on polar surface area and rotatable bonds rather than on lipophilicity directly [46].”
BackgroundEscape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403 · cited 3×
“Evidence for increased promiscuity with high lipophilicity was provided by an analysis of a set of 2,133 drugs and reference compounds from the Cerep Bioprint database, carried out by Leeson and Springthrope, that showed that promiscuity increases dramatically for logP > 3 [9].”
BackgroundMethodPrediction of Drug Absorption Using Multivariate Statistics
Egan, W. J., Merz, & Baldwin, J. J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000292e · Cited by 1,970
Ligand efficiency: a useful metric for lead selection
Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,846
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
Martin, Y. C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0492002 · Cited by 1,020
Meyer, H. (1899) · Archiv für Experimentelle Pathologie und Pharmakologie · doi:10.1007/bf01834479 · Cited by 1,014
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Quantitative approach to biochemical structure-activity relationships
Hansch, C. (1969) · Accounts of Chemical Research · doi:10.1021/ar50020a002 · Cited by 918
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
Mannhold, R., Poda, G. I., Ostermann, C., & Tetko, I. V. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21494 · Cited by 654
Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics
van de Waterbeemd, H., Smith, D. A., Beaumont, K., & Walker, D. K. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000407e · Cited by 599
Solubility and partitioning I: Solubility of nonelectrolytes in water
Yalkowsky, S. H., & Valvani, S. C. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600690814 · Cited by 577
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Methods and Principles in Medicinal Chemistry
(2008) · Methods and principles in medicinal chemistry · doi:10.1002/series6138 · Cited by 514
Do enthalpy and entropy distinguish first in class from best in class?
Freire, E. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.005 · Cited by 491 · cited 3×
“A recent study of marketed ‘first in class’ and ‘best in class’ HIV protease andHMGCoA reductase inhibitors has suggested that compounds with a greater enthalpic component to their binding affinity may be superior overall to those for which the entropic contribution is greater [56].”
BackgroundObach, R. S., Lombardo, F., & Waters, N. J. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020479 · Cited by 462
Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups
Jamieson, C., Moir, E. M., Rankovic, Z., & Wishart, G. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060379l · Cited by 423
Why Drugs Fail - A Study on Side Effects in New Chemical Entities
Schuster, D., Laggner, C., & Langer, T. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774414510 · Cited by 417
Studien über die Narkose : zugleich ein Beitrag zur allgemeinen Pharmakologie
Overton, E. (1901) · G. Fischer eBooks · Cited by 400
Using the Golden Triangle to optimize clearance and oral absorption
Johnson, T. W., Dress, K. R., & Edwards, M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.045 · Cited by 392
Camenisch, G., Alsenz, J., van de Waterbeemd, H., & Folkers, G. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10019-7 · Cited by 347
Valko, K., Nunhuck, S., Bevan, C., Abraham, M. H., & Reynolds, D. P. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10494 · Cited by 340
Time-Related Differences in the Physical Property Profiles of Oral Drugs
Leeson, P. D., & Davis, A. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049717d · Cited by 326
Waring, M. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.109 · Cited by 326
Self-citationQSAR Model for Drug Human Oral Bioavailability
Yoshida, F., & Topliss, J. G. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0000564 · Cited by 299
Summerfield, S. G., Read, K., Begley, D. J., Obradovic, T., Hidalgo, I. J., Coggon, S., Lewis, A. V., Porter, R. A., & Jeffrey, P. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121525 · Cited by 283
Effect of Altered Plasma Protein Binding on Apparent Volume of Distribution
Øie, S., & Tozer, T. N. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600680948 · Cited by 256
Physicochemical Determinants of Human Renal Clearance
Varma, M. V. S., Feng, B., Obach, R. S., Troutman, M. D., Chupka, J., Miller, H. R., & El-Kattan, A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900403j · Cited by 213
Lombardo, F., Obach, R. S., Shalaeva, M. Y., & Gao, F. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0200409 · Cited by 213
Nassar, A.-E. F., Kamel, A. M., & Clarimont, C. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03280-5 · Cited by 204
Drug Binding in Plasma: A Summary of Recent Trends in the Study of Drug and Hormone Binding
Hervé, F., Urien, S., Albengres, E., Duché, J.-C., & Tillement, J.-P. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199426010-00004 · Cited by 198
Prediction of Aqueous Solubility of Organic Compounds by the General Solubility Equation (GSE)
Ran, Y., Jain, N., & Yalkowsky, S. H. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010287z · Cited by 160
Lombardo, F., Obach, R. S., Shalaeva, M. Y., & Gao, F. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030408h · Cited by 159
A quantitative assessment of hERG liability as a function of lipophilicity
Waring, M. J., & Johnstone, C. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.061 · Cited by 159
Self-citationAdson, A., Burton, P. S., Raub, T. J., Barsuhn, C. L., Audus, K. L., & Ho, N. F. H. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841011 · Cited by 157
Peters, J., Schnider, P., Mattei, P., & Kansy, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200800411 · Cited by 150
Overcoming Roadblocks in Lead Optimization: A Thermodynamic Perspective
Ruben, A. J., Kiso, Y., & Freire, E. (2005) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00314.x · Cited by 142
Morphy, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0512185 · Cited by 121
In silicoprediction of aqueous solubility
Dearden, J. C. (2006) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.1.1.31 · Cited by 114
Dependence of Molecular Properties on Proteomic Family for Marketed Oral Drugs
Vieth, M., & Sutherland, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603825 · Cited by 102
Lewis, D. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02412-1 · Cited by 93
Wagner, J. G., & Sedman, A. J. (1973) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060026 · Cited by 82
PHYSICOCHEMICAL AND CELL-BASED APPROACH FOR EARLY SCREENING OF PHOSPHOLIPIDOSIS-INDUCING POTENTIAL
Tomizawa, K., Sugano, K., Yamada, H., & HORII (2006) · The Journal of Toxicological Sciences · doi:10.2131/jts.31.315 · Cited by 78
Bruneau, P., & McElroy, N. R. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci0504014 · Cited by 66
Camenisch, G., Folkers, G., & Waterbeemd, H. V. D. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(98)00033-5 · Cited by 51
Zachariae, U., Giordanetto, F., & Leach, A. G. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900002x · Cited by 46
Klippert, P. J. M., Borm, P. J. A., & Noordhoek, J. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90068-5 · Cited by 38
Accurate In Silico log P Predictions: One Can't Embrace the Unembraceable
Tetko, I. V., Poda, G. I., Ostermann, C., & Mannhold, R. (2009) · QSAR & Combinatorial Science · doi:10.1002/qsar.200960003 · Cited by 38
Percutaneous absorption: a multiple pathway model
Lee, A. J., King, J. R., & Barrett, D. A. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01567-2 · Cited by 36
In Silico hERG Modeling: Challenges and Progress
Diller, D. (2009) · Current Computer - Aided Drug Design · doi:10.2174/157340909788451928 · Cited by 24
Cited by
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
Roughley, S. D., & Jordan, A. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200187y · Cited by 2,725
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
Self-citationThe role of ligand efficiency metrics in drug discovery
Hopkins, A. L., Keserü, G. M., Leeson, P. D., Rees, D. C., & Reynolds, C. H. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4163 · Cited by 1,181
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Metadata
- Authors
- Waring, M. J.
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2010-02-26
- Volume
- 5
- Issue
- 3
- Pages
- 235-248
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- OpenAlex
- W2097559461
- Cited by
- 873
- References
- 57
- FWCI
- 41.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.